27 October 2003
ADMINISTRATIVE ORDER
No. 107 series 2003
GUIDELINES ON THE IMPLEMENTATION OF THE DRUG TEST
OPERATIONS MANAGEMENT SYSTEM (DTOMIS)
I. BACKGROUND/RATIONALE
The
task of regulating Drug Test Laboratories /Centers (DTL/DTC) is a function of
the Department of Health in accordance with the provisions of Republic Act No.
9165 also known as “Comprehensive Dangerous Drugs Act of 2002.”
Article
III, “Dangerous Drug Test and Record Requirement” of the said law in particular
has specifically mandated the DOH to license, accredit, and monitor Drug Test
Laboratories/Centers to ensure quality of drug testing provision of care; and
establish, operate and maintain DTL/DTCs in government hospitals.
Section
6, No. 5 of the DOH Implementing Rules and Regulation governing the licensing
and accreditation of DTLs/DTCs requires that the DOH to approve the Application
Service Provider for effective authentication of test results and prompt
interface with Information and Communication Technology (ICT) systems of Agency
Data Beneficiaries of drug test results.
On
August 27, 2003, the Congressional Oversight Committee on Dangerous Drugs
instructed the DOH to set up a “stop gap” ICT solution within one month that
will supplant the current operation of an ASP operating within the
administrative and regulation framework of the Land Transportation Office. As a
consequence of said instruction to the DOH developed the Drug Test Operations Management
System (DTOMIS) software, enhance the current available ICT infrastructure of
the DOH, and trained DOH personnel strategically distributed throughout the
country. The implementation of DTOMIS is a paramount thrust to reduce the cost
of drug testing.
And
as approved by the Dangerous Drugs Board (DDB) in its October 24, 2003 meeting,
the DTOMIS is hereby adopted for implementation and until such time appropriate
enhancements are introduced as determined by the DOH and concurred by the DDB.
II. OBJECTIVES
The
Drug Test Operation Management Information System has the following objectives:
1. To provide interconnectivity and
standardized solution for accredited DTLs/DTCs so that the results may be used
for other Agencies;
2. To provide and efficient and
effective system for updating, maintaining, sharing and accessing voluminous
transaction data that are repeated annually;
3. To enforce on input, process, and
output to simplify registration and results verification and monitoring;
4. To produce accurate, reliable and
timely drug testing data;
5. To improve client satisfaction
through better, faster, more convenient and cheaper public service;
6. To strengthen DTL/DTC quality
assurance program;
7. To generate at least Php 1
billion annual savings from the aggregate expenses of persons required to be
drug tested.
III. SCOPE AND COVERAGE
This
order shall cover all Drug Test Laboratories/Centers, the Department of Health,
including its Centers for Health Development (CHD) and Retained Hospitals, and
the Agency Data Beneficiaries.
IV. GENERAL GUIDELINES
1. Effective 03 October 2003, the
Information Management Service must assure that the DTOMIS software is deployed
to all DOH trained personnel assigned at the CHDs;
2. Effective 03 October 2003, the
DOH and its CHDs shall deploy the DTOMIS software to all DOH accredited
DTLs/DTCs. Deployment of the software to the DTLs/DTCs includes installation,
provision of minimum training and doctrine materials, and registration of Drug
Test Kits. The Drug Test Results generated from the DTOMIS shall be deemed
officially acceptable reckoned from this date;
3. Effective 03 November 2003, only
drug test results generated by DTOMIS shall be accepted as Official by the DOH
and all the Agency Data Beneficiaries. Accredited DTCs/DTLs including newly
accredited ones, however, must contact the CHD under which they are regulated
or the DOH Central Office for the installation of the DTOMIS software and
registration of drug kits onward the subject date as a continuing process;
4. The DOH shall transfer the
Security Codes for authenticating the Drug Test Results to the Head of the
Agency Data Beneficiary as shall be explicitly requested by the latter. The
Agency Data Beneficiary shall exert due diligence in protecting the
confidentiality of the said codes and the persons under it that are authorized
to have direct knowledge of the said codes. The Agency Data Beneficiary shall
explicitly identify the personnel who are authorized to have direct knowledge
of the said code and must be sworn to protect their confidentiality and must be
made aware of the implications and sanctions that may be imposed as a result of
infidelity to hold states secret.
5. The Bureau of Health Facilities
and Services, in coordination with the Information Management Service shall
harmonize regulatory standards and process with the Information and
Communication Technology Intervention and other future enhancements as may be
deemed appropriate
V. AGENCY DATA BENEFICIARIES
The
Agency Data Beneficiaries are the Government Agencies, which are members of the
Dangerous Drugs Board and other entities, as may be determined by the
Department of Health and the Dangerous Drugs Board.
VI. IMPLEMENTING ANNEXES
The
implementing annexes of this Order can be found at the DOH website for
DTOMIS
(http://dtomis.gov.ph) and are listed as follows:
Annex
A – DTOMIS Manual
Annex
B – Implementing Procedure for the Centers for Health Development
Annex
C – Implementing Procedure for the Drug Test Centers
Annex
D – Implementing Procedure for the Information Management Service
Annex
E – Terms and Conditions for DTOMIS Software Use
Annex
F – Drug Test Kit Registration Procedure
VII. REPEALING CLAUSE
Provisions
of previous issuance, which are contrary or inconsistent with those provided
in this Order are hereby rescinded or modified accordingly.
VIII. SEPARABILITY CLAUSE
If
any provision in these Guidelines or application of such provision to any
circumstance is held invalid, the remainder of these Guidelines shall not be
affected thereby.
IX. EFFECTIVITY
This
Order shall be effective immediately.
MANUEL M. DAYRIT, MD,
MSc
Secretary of Health
No comments:
Post a Comment